SCHEMBL7690396

SCHEMBL7690396

Clc1cccc(Sc2cnc3cc4ccccc4cc3n2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.51
HTT P42858 1/20 0.51
GRM5 P41594 1/20 0.48
MAPT P10636 3/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
GAA P10253 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
TP53 P04637 3/20 0.43
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 3/20 0.42
LMNA P02545 3/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP3A4 P08684 1/20 0.42
DHFR P00374 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7690413 0.83 HPGD (0.54) HPGDHTTMAPTKMT2ASMN1; SMN2
SCHEMBL7697093 0.82 SMN1; SMN2 (0.54) HPGDHTTGRM5MAPTKMT2A
SCHEMBL7692590 0.82 HTT (0.51) HPGDHTTGRM5KMT2AMEN1
SCHEMBL7696122 0.81 HPGD (0.43) HPGDHTTMAPTGAASMN1; SMN2
SCHEMBL7697610 0.80 ABCG2 (0.50) HPGDHTTMAPTKMT2AMEN1
SCHEMBL7691393 0.80 LMNA (0.54) HPGDGRM5MAPTKMT2AMEN1
SCHEMBL7695575 0.76 HTT (0.54) HPGDHTTMAPTKMT2AMEN1
SCHEMBL7696074 0.76 NPC1 (0.74) HPGDHTTMAPTKMT2AMEN1
SCHEMBL30517179 0.74 HPGD (0.50) HPGDHTTMAPTKMT2AMEN1
SCHEMBL30517180 0.74 HPGD (0.50) HPGDHTTMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002094796-A2 BENZO[G]QUINOXALINE DERIVATIVES AS EFFECTIVE COMPOUNDS AGAINST INFECTIOUS DISEASES AXXIMA PHARMACEUTICALS AG (DE) 2002-11-28 WO disclosed